Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects

Launched by DAEWOONG PHARMACEUTICAL CO. LTD. · Nov 5, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how two medications, DWC202313 and DWC202314, interact with each other when taken together. Researchers want to understand if taking these drugs together is safe and how they affect each other's levels in the body. The trial is open to healthy adults aged 19 and older, and they are currently looking for participants.

If you join the study, you will take both medications in a specific order, and the researchers will monitor your health throughout the process. It's important to know that individuals with galactose intolerance or a specific lactose deficiency cannot participate. This study aims to gather important information that could help in the future use of these medications.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • over 19 year old
• Exclusion Criteria:
• • Galactose intolerance
• • Lapp lactase deficiency